U.S. Markets close in 42 mins

Top Ranked Income Stocks to Buy for May 8th

Zacks Equity Research

Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 8th:

AbbVie Inc. (ABBV): This manufacturer and seller of pharmaceutical products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.

AbbVie Inc. Price and Consensus

AbbVie Inc. Price and Consensus

AbbVie Inc. price-consensus-chart | AbbVie Inc. Quote

This Zacks Rank #2 (Buy) company has a dividend yield of 5.49%, compared with the industry average of 2.88%. Its five-year average dividend yield is 3.57%.

AbbVie Inc. Dividend Yield (TTM)

AbbVie Inc. Dividend Yield (TTM)

AbbVie Inc. dividend-yield-ttm | AbbVie Inc. Quote

Aegon N.V. (AEG): This provider of insurance, pensions, and asset management services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.5% over the last 60 days.

Aegon NV Price and Consensus

Aegon NV Price and Consensus

Aegon NV price-consensus-chart | Aegon NV Quote

This Zacks Rank #2 (Buy) company has a dividend yield of 5.40%, compared with the industry average of 2.43%. Its five-year average dividend yield is 4.17%.

Aegon NV Dividend Yield (TTM)

Aegon NV Dividend Yield (TTM)

Aegon NV dividend-yield-ttm | Aegon NV Quote

Ambev S.A. (ABEV): This producer and seller of beer, draft beer and carbonated soft drinks has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.

Ambev S.A. Price and Consensus

Ambev S.A. Price and Consensus

Ambev S.A. price-consensus-chart | Ambev S.A. Quote

This Zacks Rank #2 (Buy) company has a dividend yield of 2.81%, compared with the industry average of 0.19%. Its five-year average dividend yield is 2.04%.

Ambev S.A. Dividend Yield (TTM)

Ambev S.A. Dividend Yield (TTM)

Ambev S.A. dividend-yield-ttm | Ambev S.A. Quote

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Aegon NV (AEG) : Free Stock Analysis Report
 
Ambev S.A. (ABEV) : Free Stock Analysis Report
 
AbbVie Inc. (ABBV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research